Document Detail


Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.
MedLine Citation:
PMID:  15894768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study whether the effect of allopurinol on improvement of endothelial dysfunction in chronic heart failure (CHF) translates into improved exercise capacity and to examine whether allopurinol also improves B-type natriuretic peptide (BNP), the other important prognostic marker of CHF. DESIGN: Randomised, double blind, placebo controlled crossover trial. SETTING: Teaching hospital. PATIENTS: 50 patients with CHF (New York Heart Association functional classes II and III) were recruited. INTERVENTIONS: 50 patients with CHF were randomly assigned to three months' treatment with allopurinol (300 mg/day) or placebo. At two and three months into treatment, they underwent a modified Bruce exercise protocol and a six minute walk test. Blood was taken for BNP and haemoglobin analysis. RESULTS: Neither exercise test was altered by allopurinol. However, plasma BNP concentrations fell significantly (p = 0.035) with allopurinol (11.9 pmol/l) versus placebo (14.4 pmol/l). Haemoglobin concentrations also fell highly significantly with allopurinol (p = 0.001). CONCLUSIONS: An important negative finding is that despite high hopes for it, allopurinol had no effect on exercise capacity in CHF. On the other hand, allopurinol did reduce BNP, which is the best available surrogate marker for prognosis in CHF.
Authors:
A D Gavin; A D Struthers
Related Documents :
8233998 - Clinical trial strategies and future challenges in the investigation of human congestiv...
16911248 - Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availab...
8995988 - Cardiorespiratory response to exercise after venous switch operation for transposition ...
2125668 - The role of oxygen extraction in peripheral tissues in exercise capacity in chronic hea...
11579748 - The impact of psychological stress on immune function in the athletic population.
12218738 - Perceptual versus physiological heat strain during exercise-heat stress.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  91     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-16     Completed Date:  2005-07-07     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  749-53     Citation Subset:  AIM; IM    
Affiliation:
Division of Medicine & Therapeutics, Ninewells Hospital & Medical School, Dundee, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Allopurinol / therapeutic use*
Analysis of Variance
Biological Markers / blood
Chronic Disease
Cross-Over Studies
Double-Blind Method
Endothelium, Vascular / drug effects
Enzyme Inhibitors / therapeutic use*
Exercise Tolerance / drug effects
Female
Heart Failure / blood,  drug therapy*,  enzymology
Hemoglobins / metabolism*
Humans
Male
Natriuretic Peptide, Brain / blood*
Ventricular Dysfunction, Left / blood,  drug therapy*,  enzymology
Xanthine Oxidase / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Enzyme Inhibitors; 0/Hemoglobins; 114471-18-0/Natriuretic Peptide, Brain; 315-30-0/Allopurinol; EC 1.17.3.2/Xanthine Oxidase
Comments/Corrections
Comment In:
Heart. 2005 Jun;91(6):707-9   [PMID:  15894755 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long term clinical and echocardiographic results of mitral balloon valvotomy in children and adolesc...
Next Document:  Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary a...